Digitalisation and artificial Intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 November 2026, 09:30 (CET) to 19 November 2026, 17:30 (CET)

Human medicines European public assessment report (EPAR): KemSu, sufentanil,ketamine, Status: Opinion under re-examination

Presentation - Challenges and opportunities in medicines and medical devices development (S. Dias)

Presentation - Adiposity: The gateway to cardiometabolic diseases (L. Fábryová)

Presentation - Cardiometabolic diseases: Tackling the unmet need in CV risk reduction (F. Giorgino)

Presentation - Cardiometabolic diseases: tackling the unmet need in cardiovascular risk reduction (J. Nabais)

Presentation - Global collaboration in cardiovascular medicine development (M. Inoue)

Presentation - Clinical imperatives for implementing regulatory science for medical devices (A. Fraser)

Presentation - Recent (regulatory) developments in medicines for cardiovascular indications (A. Irs)

Presentation - Clinical research: opportunties and challenges (T. Lüscher)